Alignment Healthcare, Inc. ALHC 深 沪
等待开盘 02-03 09:30:00 美东时间
22.65
+0.120
+0.53%
华盛通- 最 高22.82
- 今 开22.45
- 成交量 269.63万股
- 最 低 22.07
- 昨 收 22.53
- 总市值 45.30亿
- 52周最高 23.87
- 市盈率 静 --
- 换手率 1.35%
- 52周最低 11.625
- 委 比 94.80%
- 总股本 2.00亿
- 历史最高 28.592
- 量 比 0.63
- 振 幅 3.33%
- 历史最低 4.46
- 每 手 1
- 风险率 2.50%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Astrana Health Stock Slide Presents An Attractive Entry Point: Analyst
Astrana Health shares fell 22% after CMS proposed modest Medicare Advantage growth, but analyst says sell-off looks overdone and long-term benefits may emerge.
01-28 19:38
Healthcare lobbying efforts reach record high in Washington: report
Drugmakers, hospitals, and health insurers have pumped record sums of funds into lobbying activities in Washington last year as the government continued its efforts to lower healthcare expenditure in ...
01-28 03:21
A Glimpse of Elevance Health's Earnings Potential
Elevance Health (NYSE:ELV) is set to give its latest quarterly earnings report ...
01-27 23:02
Medicare Shock Sends UnitedHealth, Humana And CVS Tumbling
The CMS proposed modest payment growth for Medicare Advantage in 2027 and emphasized sustainability, accuracy, and simplicity.
01-27 20:17
Why Biomx Shares Are Trading Higher By Over 100%; Here Are 20 Stocks Moving Premarket
Shares of Biomx Inc (NYSE:PHGE) rose sharply in pre-market trading after a 13D ...
01-27 17:51
Alignment Healthcare Inc. Files Initial Beneficial Ownership Statement for Chief Digital Officer Adnan R. Mansour
Alignment Healthcare Inc. Files Initial Beneficial Ownership Statement for Chief Digital Officer Adnan R. Mansour Alignment Healthcare Inc. has filed an initial statement of beneficial ownership with the U.S. Securities and Exchange Commission. The filing names Adnan R. Mansour as the beneficial own
01-22 05:28
美股大行评级 | 潜在上涨空间31.6%！巴克莱上调台积电目标价至450美元；第一地平线全国银行获5家机构上调目标价
今日重点评级关注：Guggenheim：维持MBX Biosciences"买入"评级，目标价从77美元升至88美元；摩根士丹利：维持DraftKings"超配"评级，目标价从50美元升至53美元
01-20 10:26
美股大行评级 | 英特尔、美光科技、SanDisk等获大行上调目标价；纽约梅隆银行获5家大行上调目标价
今日重点评级关注：HC Wainwright & Co.：维持Rezolve AI"买入"评级，目标价从10美元升至12美元；HC Wainwright & Co.：维持Largo"买入"评级，目标价从2.9美元升至3.1美元
01-15 16:10
UBS Maintains Neutral on Alignment Healthcare, Raises Price Target to $21
UBS analyst Kevin Caliendo maintains Alignment Healthcare (NASDAQ:ALHC) with a Neutral and raises the price target from $18 to $21.
01-15 00:10
